Zacks Investment Research on MSN
Organon secures FDA approval extending NEXPLANON use to five years
Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of ...
Nexplanon is a brand-name birth control implant that a healthcare professional inserts under the skin of your upper arm. It is very effective at preventing pregnancy for up to 3 years. Nexplanon ...
Nexplanon (etonogestrel) is a brand-name birth control implant prescribed to help prevent pregnancy. Nexplanon has interactions with some other drugs and certain herbal supplements. Examples include ...
Full-year 2025 revenue guidance is set between $6.125 billion to $6.325 billion. Kevin Ali stated, "On a constant currency basis, the midpoint of this range would reflect flat revenue performance," ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results